ULTRASHORT-COURSE TREATMENT OF DRUG-SENSITIVE AND DRUG-RESISTANT TUBERCULOSIS VIA INHALATION AND NANOTHERAPEUTIC DELIVERY OF NOVEL DRUG REGIMEN
$790,997FY2020Defense Health AgencyDOD
University Of California, Los Angeles
University Of California, Los Angeles